List of Studies ( Metabolite:Glutaral)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | intensity |
| ST001788 | AN002900 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | Intensity | |
| ST001953 | AN003178 | Identifying metabolite changes in human islets treated with Phospho-BAD mimicry and Inflammatory cytokines | Cultured cells | Human | Diabetes | Harvard University | Ion signal intensity |
| ST001324 | AN002202 | Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress | Pacific Abalone | Institute of Oceanology, Chinese Academy of Sciences | mV*min | ||
| ST000148 | AN000235 | A549 13C-labeled Cell Study | Epithelial cells | Human | Cancer | University of Kentucky | normalized corrected peak area |
| ST000142 | AN000225 | H1299 13C-labeled Cell Study | Lung | Human | Cancer | University of Kentucky | Peak area |
| ST001658 | AN002706 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Yeast | Cancer | Johns Hopkins University | Peak area |
| ST002505 | AN004126 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | Peak area |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000421 | AN000664 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000668 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST001549 | AN002580 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | Peak intensity | |
| ST000883 | AN001440 | Breathprinting Reveals Malaria-Associated Biomarkers and Mosquito Attractants | Breath | Human | Washington University School of Medicine | raw abundance | |
| ST000045 | AN000072 | Plasma metabolomics: Comparison of non-diabetic controls with T1D patients | Blood | Human | Mayo Clinic | Raw MS Intensities | |
| ST000045 | AN000075 | Plasma metabolomics: Comparison of non-diabetic controls with T1D patients | Blood | Human | Mayo Clinic | Raw MS Intensities | |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000083 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
